SynthesisFrontiers in oncology2025

Reduced versus standard dose apixaban for secondary prevention of cancer-associated venous thromboembolism: A systematic review and meta-analysis.

Vasu Malhotra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.